ISHARES TR - GENOMICS IMMUN (IDNA)
Historical Holders from Q1 2019 to Q4 2025
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Symbol
-
IDNA
-
Price per share
-
$26.19
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares as of 30 Sep 2025
-
2,066,161
-
Holdings value
-
$48,778,790
-
% of all portfolios
-
0%
-
Share change
-
-83,044
-
Value change
-
-$1,713,848
-
Average buys %
-
+0%
-
Average sells %
-
-0%
-
Number of holders
-
50
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
As of 30 Sep 2025, ISHARES TR - GENOMICS IMMUN (IDNA) has 50 institutional shareholders filing 13F forms.
They hold 2,066,161 shares
.
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) across Reporting Periods
| Period |
Reported Shares, Excl. Options |
Value, Excl. Options |
Value Change |
Puts Notional Value |
Calls Notional Value |
Price |
Investors |
|
2025 Q4
|
34,876 |
$913,400 |
-$59,636 |
|
|
$26.19 |
2 |
|
2025 Q3
|
2,066,161 |
$48,778,790 |
-$1,713,848 |
|
|
$23.61 |
50 |
|
2025 Q2
|
2,149,205 |
$44,080,900 |
+$15,105 |
|
|
$20.51 |
47 |
|
2025 Q1
|
2,165,537 |
$44,367,995 |
-$284,948 |
|
|
$20.49 |
48 |
|
2024 Q4
|
2,156,744 |
$48,817,902 |
+$10,336,199 |
|
|
$22.63 |
59 |
|
2024 Q3
|
1,679,914 |
$41,330,282 |
-$5,490,532 |
|
|
$24.61 |
52 |
|
2024 Q2
|
1,949,635 |
$45,082,190 |
+$1,992,117 |
|
|
$23.12 |
61 |
|
2024 Q1
|
1,861,162 |
$44,785,349 |
-$3,563,529 |
|
|
$24.08 |
61 |
|
2023 Q4
|
1,873,122 |
$43,113,932 |
+$5,820,706 |
|
|
$23.01 |
63 |
|
2023 Q3
|
1,618,890 |
$32,867,922 |
-$4,993,482 |
|
|
$20.35 |
62 |
|
2023 Q2
|
2,047,511 |
$47,854,590 |
+$556,766 |
|
|
$23.35 |
65 |
|
2023 Q1
|
2,026,327 |
$47,182,262 |
+$3,452,845 |
|
|
$23.27 |
72 |
|
2022 Q4
|
1,800,429 |
$45,253,510 |
+$525,110 |
|
|
$25.17 |
73 |
|
2022 Q3
|
1,775,333 |
$46,863,997 |
-$4,202,431 |
|
|
$26.39 |
63 |
|
2022 Q2
|
1,910,925 |
$55,213,090 |
-$8,773,853 |
|
|
$28.90 |
64 |
|
2022 Q1
|
2,121,568 |
$73,089,864 |
-$21,921,812 |
|
|
$34.45 |
77 |
|
2021 Q4
|
2,599,170 |
$115,244,636 |
+$23,167,842 |
|
|
$43.81 |
99 |
|
2021 Q3
|
2,041,897 |
$108,478,521 |
+$8,198,908 |
|
|
$50.71 |
85 |
|
2021 Q2
|
1,886,708 |
$103,362,867 |
+$1,108,604 |
|
|
$52.03 |
82 |
|
2021 Q1
|
1,871,621 |
$90,062,890 |
+$20,206,336 |
|
|
$45.71 |
78 |
|
2020 Q4
|
1,425,698 |
$65,458,807 |
+$14,908,374 |
|
|
$45.94 |
62 |
|
2020 Q3
|
1,113,876 |
$43,302,330 |
+$10,503,704 |
|
|
$38.96 |
44 |
|
2020 Q2
|
850,218 |
$29,687,175 |
+$17,483,549 |
|
|
$37.96 |
32 |
|
2020 Q1
|
233,647 |
$6,278,000 |
+$6,269,001 |
|
|
$26.87 |
1 |
|
2019 Q4
|
742,636 |
$22,333,000 |
-$2,531,710 |
|
|
$30.00 |
5 |
|
2019 Q3
|
826,968 |
$20,452,000 |
+$14,310,098 |
|
|
$29.41 |
3 |
|
2019 Q2
|
239,381 |
$6,677,000 |
+$6,317,999 |
|
|
$27.17 |
4 |
|
2019 Q1
|
6,900 |
$359,000 |
$0 |
|
|
$52.03 |
1 |